Research News - September 3, 2021

 

         
 
September 3, 2021
ANNOUNCEMENTS
 

1. The 2021 MGRI Image Awards have begun!
2. Learn Something New! Series
3. Employee COVID-19 Vaccine Requirements and Deadlines
4. Annual ECOR Elections – Nominations are Open!
5. Travel Advisory: Clean Laptop / Phone Program for Travel to Countries Deemed High Risk
6. Applying for the Claflin Awards? ECOR and the Office for Women’s Careers are offering help with your application

EVENTS
 

1. Informed Consent in Clinical Research
2. Strategies for Managing Investigator-Initiated Studies
3. Artificial Intelligence for Clinicians (AI4C) Virtual Lecture Series
4. Health Care’s Responsibility at the Intersection of Climate, Health and Racial Equity
5. Funding Your Research: How to Obtain Foundation and Philanthropic Grants
6. Claflin Distinguished Scholar Awards Panel Discussion
7. Greening the Lab: Reducing the Environmental Footprint of Your Laboratory
8. SAVE THE DATE! Virtual Nursing Research Day
9. IDEA Symposium: Digital Health Project Selection: Finding the Right Fit
10. MGH will celebrate the 19th Annual Clinical Research Day
11. 2021 Virtual Tumor Course

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. Fund for Medical Discovery (FMD) Research Fellowship Awards
3. The MGH Claflin Distinguished Scholar Awards
4. NIMH Instrumentation Program
5. NIH Research Supplements to Promote Diversity in Health-Related Research
6. Job Research Foundation Announces 4th Round of Funding
7. NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
8. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592
9. Limited Submission Funding Opportunities
10. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. The 2021 MGRI Image Awards have begun!

The Mass General Research Institute (MGRI) Image Contest was created in 2018 to showcase the breadth of research occurring across Massachusetts General Hospital. We receive so many great images each year that it’s become increasingly difficult to select one winner. So this year, we’re proud to reimagine the MGRI Image Contest into the MGRI Image Awards.

With the new name comes new categories and more opportunities to highlight the many faces of research at Mass General. Learn more about the 2021 Awards on Bench Press and enter now through September 24! massgeneral.link/2021-image-awards

 
2. Learn Something New! Series

Click here for a full list of topics and dates

Clinical research is complicated. It is governed by regulations, guidelines, and institutional policies. It involves people inside and outside of the institution, in clinical areas, doing financial management, etc. But you don’t have to do it all on your own! Join the DCR’s network of study coordinators, research assistance, and project managers to learn something new about different clinical research operations topics. With something for everyone, these sessions cover how to’s on protocols, basic study designs, informed consent, managing your day to day, and many more.

To get the most out of this program, you should have already completed the CITI Training in Human Subjects Research and Clinical Research Conduct: Research Staff Training prior to enrolling. It is also recommended that you take Good Clinical Practice in an Academic Research Institution prior to enrolling.

Contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
3. Employee COVID-19 Vaccine Requirements and Deadlines

As Mass General Brigham President and CEO Anne Klibanski, MD, previously communicated, the pandemic’s changing landscape — particularly, the rise of the highly transmissible Delta variant — has required us to reevaluate the timing of our COVID-19 vaccination requirement for staff.

Vaccination remains our best defense against this virus. The available vaccines are safe and effective at preventing serious illness and death from COVID-19. As health care workers, we all have a responsibility to protect not only the vulnerable populations we care for but also ourselves and our colleagues.

To ensure the safety of our patients, their loved ones and our workforce, all MGH staff must be fully vaccinated and document their vaccination status by Friday, October 15, 2021 (meaning that you must receive both doses of Pfizer or Moderna, or a single dose of Johnson & Johnson, by this date). This is a condition of employment. Failure to meet this deadline will result in loss of Epic/computer access, unpaid administrative leave and, if noncompliance continues, termination of employment.

The following provides a quick summary of key deadlines. Please see below for further details about each of these items.

  • September 3 – Medical and/or religious exemption requests
  • September 13 - Clearance for new hires
    • Actions required: New hires who have their Occupational Health visit starting on September 13 must have their COVID-19 vaccination status validated by Occupational Health to begin work.
  • September 16 - If unvaccinated: Deadline for first dose of Moderna vaccine
    • Actions required: Receive the vaccine and, for non-Mass General Brigham sites, obtain proof of vaccination.
  • September 23 - If unvaccinated: Deadline for first dose of Pfizer vaccine
    • Actions required: Receive the vaccine and, for non-Mass General Brigham sites, obtain proof of vaccination.
  • October 13 - COVID-19 vaccination deadline
    • Actions required: Complete your full COVID-19 vaccination series (i.e., receive either two doses of Pfizer/Moderna or one dose of Johnson & Johnson). After vaccination, you need to report and document your vaccination status. It is not done automatically.

How can I get the COVID-19 vaccine?

  • Appointments are available on the main campus. Schedule an appointment in COVID Pass or call Occupational Health Services (OHS) at 617-732-6034.
  • Schedule an appointment at a community-based vaccine clinic at locations across Massachusetts . These clinics offer free vaccines at convenient hours, including evenings and weekends.

I already got my COVID-19 vaccine. Do I need to do anything else?
Yes. Similar to our seasonal flu shot program, our COVID-19 vaccination program requires all staff to provide proof of vaccination to Occupational Health. Your vaccine status is not shared automatically, even if you received your vaccine at an MGB location.
Before October 15, 2021 you must document your COVID-19 vaccine by doing one of the following:

  • If you received your vaccine at a Mass General Brigham clinic, please complete this survey to consent to share your vaccination record with Occupational Health. Log in using your Mass General Brigham login and password and select MGB Sponsored Vaccine Clinic to navigate to the consent question.
  • If you received your vaccine anywhere outside of Mass General Brigham (such as a retail pharmacy), complete this survey to record and upload your vaccine documentation. Log in using your Mass General Brigham login and password and select Non-MGB Vaccine Clinic or Outside Provider to submit your documentation.

Can I be exempted from the vaccine requirement?
Staff seeking an exemption from the COVID-19 vaccine requirement for medical or religious reasons must submit an exemption request. The deadline for this is Friday, September 3, 2021.

  • The medical exemption form can be downloaded here. This form must be completed and signed by your health care provider.
  • The religious exemption request form can be accessed here.

What happens if I wait until October 15 to get the COVID-19 vaccine?
Unless you obtain the single-dose Johnson & Johnson vaccine, you will not be able to meet the deadline.  To meet the October 15 deadline with a Pfizer or Moderna vaccine, employees must receive their first dose by the following dates:

  • Moderna: Thursday, September 16, 2021
  • Pfizer: Thursday, September 23, 2021

What about new hires?
Starting September 13, 2021 all new hires who have their Occupational Health visit on or after this date must have their COVID-19 vaccine status validated by Occupational Health before they can receive clearance to start work.

New hires can present documentation of either a first dose or both doses (Pfizer/Moderna) or single dose (Johnson & Johnson). New hires who have only received their first dose of Pfizer or Moderna by the time of their Occupational Health visit will receive temporary clearance and must follow-up with Occupational Health after receiving their second dose for final clearance.
I have another question not addressed here.
Answers to other frequently asked questions are available on Pulse.

 
4.  Annual ECOR Elections – Nominations are Open!

ECOR representatives should be able to speak to the interests and concerns of their colleagues (fellow MGH faculty members) in discussions and planning for research at MGH.  To learn more about ECOR or the responsibilities of an  Elected Representative to ECOR, please visit click here

Click here to nominate yourself or a colleague!

Nominations Deadline: Wednesday, September 22, 2021

- TWO OPENINGS -
One Assistant Professor
One Professor

Who is eligible to nominate?
All MGH faculty with an academic rank of Assistant, Associate, or Full Professor, and who are primarily researchers, are eligible to nominate.

Questions? ECOR@mgh.harvard.edu

 
5. Travel Advisory: Clean Laptop / Phone Program for Travel to Countries Deemed High Risk

Mass General Brigham (MGB) Information Security and Privacy Office is issuing this Information Security and Privacy Memorandum to notify all impacted individuals and business units that business travel to China, Russia and other high-risk countries, whether for research, clinical or consulting purposes, creates specific information security challenges that must be addressed in order to effectively secure MGB’s data and assets. The Clean Laptop/Phone Program has been put in place to address these concerns.

Travel Statement                                                                        

All MGB workforce members traveling to China, Russia or other countries identified as high risk by the Department of Commerce must take special care to ensure MGB’s data and assets are properly secured, due to the fact that personal privacy may not be respected. Even private spaces such as hotel rooms, rental cars, and taxis may be subject to video, audio, or other monitoring. Workforce members are advised to assume that anything done on any device, particularly over the Internet, may be intercepted. In some cases, encrypted data may be decrypted. To that end, the following security controls must be followed by any individual conducting MGB business in China, Russia, or other high-risk countries.

Prior to Travel

Access to MGB network resources from these countries is limited to MGB workforce members. Workforce members intending to access MGB resources from these countries must complete the following steps prior to travel:

  • When you make your transportation arrangements, register your travel plans (including dates of travel) with the MGB Travel Safe Program.

  • Review the Department of Commerce high-risk country list, specifically countries listed as high risk for National Security and Chemical & Biological purposes. If your travel destination appears on this list, contact your hospital Export Control Officer to determine whether you should take advantage of the clean laptop program while traveling or if there are country-specific export controls requirements that must be addressed prior to traveling.

  • Contact your hospital’s Information Security Officer (ISO) no less than 10 days prior to departure to request a clean computer and mobile phone. Do not bring or use your regular devices during your trip1 .

    • Clean phone program requires an update to Mass General Brigham’s myprofile.partners.org to include the international calling number for multi-factor authentication.

  • Change all passwords prior to departure.

  • Backup your laptop and/or phone before departure.

  • Leave unneeded car keys, house keys, smart cards, credit cards, swipe cards, employee badge or fobs you would use to access your workplace, or other areas, and any other access control devices you may have at home.

  • Remove any financial information such as bank account numbers, logins and passwords you may have in your purse or wallet.

  • Document the account numbers to anything you do take, so that if lost/stolen, you know what is missing.

  • Obtain and use an RF-shielded cover or case for any RFID cards (including U.S. Government Nexus “trusted traveler” cards) that you do plan to take with you.

During Travel

Never use shared computers in cyber cafes, public areas, hotel business centers, and never use devices belonging to other travelers, colleagues, or friends.

  • Use Citrix to connect to MGB resources (workspace.partners.org).

  • Rigorously apply minimum necessary principles to all information accessed, used or obtained.

  • When not in use, completely logout of applications accessed and fully power down devices. Do not allow them to be in “sleep” or “hibernation” mode, make sure they are shutdown.

  • Keep device(s) with you at all times during your travel. Do not assume they will be safe in your hotel room or in a hotel safe.

  • Do not send sensitive messages.

  • Disable and fully cover any integrated laptop cameras.

  • Physically disconnect any integrated laptop microphones.

  • Be aware of your surroundings and shoulder surfing. Position yourself to minimize this opportunity for others.

  • Disable all unnecessary network protocols, (e.g., Wi-Fi, Bluetooth, infrared, location services, GPS, etc.)

  • Do not plug your phone into charger kiosks. There may be a hostile computer on the other end of that innocent-looking wire.

  • Access to services that we take for granted like Gmail and other Google apps, Wikipedia, and Yahoo Web Mail are often blocked altogether or monitored/filtered.

  • Do not store any sensitive data on your devices while traveling overseas.

  • Do not use or borrow others' USB memory sticks.

Upon Return to United States

Upon return to the United States and prior to re-connecting to any MGB network or technology, MGB workforce members must complete the following.

  • Immediately discontinue use of the temporary device(s) you brought with you. The hard drive of the devices should be reformatted, and the operating system and other related software reinstalled prior to being reconnected. 

  • Delete any data stored on such devices listed above.

  • Change all passwords you may have used abroad from an alternate device (other MGB/Institution workstation/Laptop).

  • Do not plug in any USB memory sticks that you have obtained/received during travel.

  • Return the devices by contacting the IS Service Desk site techs for pickup. Ensure you notify them the devices were on international travel.

Applicability

This advisory is applicable to any Mass General Brigham workforce member who is conducting approved business from China, Russia or other high-risk countries. 
For questions regarding whether a country is high risk, contact your hospital’s export control officer here
For all other questions regarding the Clean Laptop/Phone Program, contact your hospital ISO.

Resources

1 If you bring your smartphone, you will need to install the Okta Verify application to support multi-factor authentication for international access.

 
6. Applying for the Claflin Awards? ECOR and the Office for Women’s Careers are offering help with your application

If you are applying for a Claflin Award, and would like help preparing your application, ECOR and the Office for Women’s Careers (OWC) encourages you to take advantage of the Claflin Consultation Initiative (CCI) for applicants.

The CCI is designed to help eligible faculty prepare their best application for the 2022 Claflin Distinguished Scholar Awards. Many prior Claflin winners have volunteered their time to answer questions and offer guidance and encouragement to potential applicants. Coaches may give advice on all aspects of the application, including the research plan, budget, and the description of child-rearing responsibilities.

Please click here to enroll in the Claflin Consultation Initiative by Tuesday, September 28.

To review your eligibility please click here or email ecor@mgh.harvard.edu before registering for the CCI.

 
Back to top
EVENTS
 
1. Informed Consent in Clinical Research

Tuesday, September 7, 2021, 11:00 AM – 12:00 PM, Zoom

In this session, we will briefly review regulations and polices involved in the informed consent process. The goal of this session is to teach new study coordinators how to present a study to a potential subject and obtain consent correctly, without breaking the law and totally embarrassing yourself and your PI. 

Presented By: Stacey Ellender, Senior Clinical Research Project Manager, Center for Clinical Research Operations, Mass Eye and Ear.

Audience: Study staff new to clinical research with less than 1 year of research-related experience or experienced study staff looking to learn the basics of a new skill. 

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.
 
2. Strategies for Managing Investigator-Initiated Studies

Wednesday, September 8, 2021, 11:00 AM – 12:00 PM, Zoom

As compared to Sponsor-initiated studies, Investigator-initiated studies offer scientists the opportunity to perform the research exactly as they design it. However, this opportunity also increases the responsibilities of the study team. Unlike industry sponsored studies, Investigator-initiated studies often have more flexible study protocols and procedures and reduced external oversight. This session will give you key insights into study design and set-up, milestone planning and development, further strategies to monitor studies throughout their tenure and close out, and information that can assist in reducing potential errors and protocol deviations. 

Presented by: Maryam Masood, Senior Clinical Research Coordinator, Center for Neurotechnology and Neurorecovery (CNTR), Department of Neurology 

Audience: Study staff new to clinical research with less than 1 year of research-related experience or experienced study staff looking to learn the basics of a new skill. 

Register here. Please contact tmorrison-rohlfs@partners.org with questions.

Click here to learn more.

 
3. Artificial Intelligence for Clinicians (AI4C) Virtual Lecture Series

Thursday, September 9, 2021, 12:00 – 1:00 PM, Zoom

“Radiology AI During the COVID-19 Pandemic:  A Personal Journey and Lessons Learned”
Matthew D. Li, MD

Matthew D. Li, MD, is a diagnostic radiology fellow and former chief resident in the department of radiology at Massachusetts General Hospital and Harvard Medical School. Since the start of the COVID-19 pandemic, he has been involved in the care of COVID-19 patients, research on the imaging manifestations of COVID-19, and the development and implementation of an artificial intelligence tool for improving the consistency of radiologist interpretations of COVID-19 chest radiographs. As a member of Jayashree Kalpathy-Cramer's research team, he published one of the first peer-reviewed research studies applying deep learning to the analysis of COVID-19 lung disease severity on chest radiographs

Please click here to register for September’s AI4C event on Eventbrite, and feel free to forward to anyone who may be interested!

Abstract: Numerous imaging-based artificial intelligence (AI) models were developed in response to the COVID-19 pandemic, but recent literature has highlighted systemic issues including methodological flaws and problems for real-world deployment. This talk aims to help the clinician understand the nuances that impact the clinical deployment of AI for COVID-19 imaging, drawing on personal experiences and lessons learned at a large academic medical center.

AI4C Virtual Lecture Series are now CME approved! MDs, DOs, NPs, and PAs can receive CME Category 1 Credit. Other health care professionals can get participation certificates including Information Technology professionals. Use this link to register: September 9, 2021 AI4C: Radiology AI During the COVID-19 Pandemic: A Personal Journey and Lessons Learned

 
4. Health Care’s Responsibility at the Intersection of Climate, Health and Racial Equity

Wednesday, September 15, 2021, 12:00 – 1:00 PM, Zoom

Monthly Grand Rounds webinars on climate, the environment, and health: Co-hosted by the MGH Center for the Environment and Health and the MGH IHP Center for Climate Change, Climate Justice, and Health

Gary Cohen, president of Health Care Without Harm and Practice Greenhealth, will explore the role of health care in climate change and racial equity.

Register to attend or receive link to recording by clicking here.

 
5. Funding Your Research: How to Obtain Foundation and Philanthropic Grants

Wednesday, September 15 – Wednesday, November 10

Online course: Identify and apply for foundation and philanthropic grant funding, exploring the differences between these two funding sources. Researchers who have been successful share their stories. Open to all MDs, investigators, and researchers.

Applications due September 1.

 
6. Claflin Distinguished Scholar Awards Panel Discussion

Wednesday, September 22, 2021, 11:00 AM – 12:00 PM, Zoom

Would you like to know more about the Claflin Distinguished Scholar Awards

These awards are designed to provide bridge funding for women with an HMS faculty appointment of instructor or assistant professor, to sustain research productivity during the child-rearing years, with the intention of advancing women in academic medicine. The discussion will cover:

  • Eligibility requirements
  • Resources to improve your application
  • Advice from recent Claflin Scholars
  • How the award can advance your career

Join Zoom Meeting: https://partners.zoom.us/j/87201164559
Meeting ID: 872 0116 4559
Dial by your location
        +1 301 715 8592 US (Washington DC)
        +1 312 626 6799 US (Chicago)
        +1 646 876 9923 US (New York)
  
Find your local number: https://partners.zoom.us/u/k0BVCG7Sb
Join by SIP: 87201164559@zoomcrc.com

 
7. Greening the Lab: Reducing the Environmental Footprint of Your Laboratory

Thursday, September 23, 2021, 12:00 – 1:00 PM, Zoom

Ilyssa Gordon, MD, PhD, Associate Professor of Pathology, Medical Director, Sustainability, Cleveland Clinic

Reagent bottles.... pipette wrappers.... heating blocks... freezers.   All of these are essential parts of laboratory activity.  However, they also yield waste and use energy, which ultimately contribute to climate change.   In this session, Dr. Ilyssa Gordon will share how your laboratory can step up to help mitigate the climate impact of our work, including both practical recommendations and an overview of national efforts to inspire you.

Register here.

Please contact tmorrison-rohlfs@partners.org with questions or click here to learn more.

 
8. SAVE THE DATE!  Virtual Nursing Research Day

Thursday, September 30, 2021, 1:30 – 3:00 PM

We are excited to share with you that the Munn Center will host its second Virtual Nursing Research Day comprised of the annual Nursing Research Lecture and Presentation of Awards (grants and posters) as well as the Virtual Poster Showcase. This event will take place on Thursday, September 30th, from 1:30 - 3 pm, and details including registration, the link to the Virtual Poster Showcase, and the virtual session are forthcoming.

We are excited to showcase on the Munn Center website 40 posters that demonstrate the incredible work of MGH nurses in Evidence Based Practice, Original Research, and Quality Improvement. We will also recognize our exceptional grant recipients.

We look forward to this year’s speaker:  

Rosa Gonzalez-Guarda, PhD, MPH, RN, CPH, FAAN
Associate Professor of Nursing, Duke University School of Nursing
Faculty Lead, Population Health Research Area of Excellence, Duke University’s Center for Nursing Research
Co-Director, Community Engagement Core, Clinical Translational Science Institute, Duke University

Presentation title:  Nursing’s Role in Leading and Improving Health Equity through Research: Lessons Learned from Addressing Health Disparities among Latinx Immigrants in the US.

We hope you can join us. Please reach out munncenter@partners.org with any questions.

 
9. IDEA Symposium: Digital Health Project Selection: Finding the Right Fit

Thursday, September 30, 2021, 3:30 PM, Zoom

Mass General Brigham offers a wide-range of resources to support innovation. Hear from system leaders about the environments available to facilitate digital health innovation. Join Jeffrey Phillips, MD, Innovation Director – Ambulatory Services, Department of Family Medicine, NWH, Michael Ricci, Chief Information Officer, Vice President of IS, Massachusetts Eye & Ear Infirmary, MGB, and Marissa Fox-Foley, Chief Strategy and Marketing Officer, AllWays Health Partners, to learn more about collaboration and incubation in the digital health space. Click here to register  

About MGB Innovation Digital Education Academy (IDEA) Symposium
Mass General Brigham Innovation Digital Education Academy (IDEA) Symposium is a new, year-long program focused on Innovation and Digital Health. Designed for faculty, staff, and innovators within our System, each month will feature a theme with speaker(s) working on innovations and initiatives within the digital health space.   The following events are only open to Mass General Brigham employees. IDEA webpage: Learn more

 
10. MGH will celebrate the 19th Annual Clinical Research Day

Thursday, October 14, 2021, 8:00 AM – 12:00 PM

To learn more about MGH Clinical Research Day 2021 please visit the portal.

 
11. 2021 Virtual Tumor Course

Monday, November 2, 2021 – Thursday, November 4, 2021

36TH Critical Issues in Tumor Microenvironment Angiogenesis, Metastasis and Immunology

For comprehensive information about this course, including faculty, schedule, and pricing, please visit the 36th Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology website

The “36th Annual Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” course, directed by Professor Rakesh K. Jain, will continue to offer the best in critical analysis of what is currently known about the tumor microenvironment, angiogenesis, metastasis, immunology, metabolism and chronobiology. This will include chimeric antigen receptor (CAR) T-cell therapies and the role of microbiome as newly introduced topics this year. The faculty is internationally recognized. They will present their latest findings from their clinics and laboratories. The goal is to highlight key gaps in present knowledge of cancer and outline future directions for research at the bench, in the clinic, and in drug development.

The course will continue its four-day online webinar-based live lecture format. Learning formats will include didactic lectures, Q&A and group discussions. The faculty will encourage an open discussion and will provide critical comments on challenges and future opportunities in research in cancer and in establishment of novel therapy approaches and biomarkers to guide treatment. The aim of this course is to analyze and synthesize the most up-to-date findings. Our faculty will present valuable information in a systematic and comprehensive framework, along with a critical review of various measurement techniques. This course is dedicated to helping to improve clinical translation of this knowledge and competence, leading to improved cancer treatment.  

Harvard Medical School’s secure online registration.

Click here to for an overview 

Click here to view the brochure
 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines:

Recently added:

  • No new additions
 
2. Fund for Medical Discovery (FMD) Research Fellowship Awards

Applications are now being accepted by the Executive Committee on Research (ECOR) for the Fund for Medical Discovery (FMD) Research Fellowship Awards!

What are they?
We recognize that research at MGH integrates the full translational spectrum of discovery from "bench to bedside to community and population.” To ensure that all areas of research conducted at MGH are included and eligible for FMD fellowship awards, ECOR is offering 3 types of training awards: fundamental research fellowships, clinical research fellowships, and population healthcare sciences fellowships. These fellowships are for MD and PhD Research Fellows and Clinical Research Fellows who are in the training phase of their research at MGH and Instructors who are within 5 years total since initiating their research fellowship training.  

How much is each award?
The award will include a stipend of $53,760 plus applicable fringe benefits and 15% indirect costs.

When is the deadline?
Friday, October 1, 2021 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online!

For a guide to help make your application more competitive click here. 

 
3. The MGH Claflin Distinguished Scholar Awards

Applications are now being accepted by the Executive Committee on Research (ECOR) for the Claflin Distinguished Scholar Awards!

What are the Claflin Awards?
Although women scientists are recruited to Massachusetts General Hospital (MGH) programs, their advancement to senior faculty positions is still far less frequent than that of their male counterparts.  In 1993, The Women in Academic Medicine Committee, originally chaired by Mrs. Jane D. Claflin, Honorary Trustee, was established to facilitate the academic careers of women in science at MGH.  Recognizing that a significant obstacle to career advancement is the difficulty of maintaining research productivity during the child-rearing years, this Committee, with the sponsorship of the Executive Committee on Research (ECOR), established the Claflin Distinguished Scholar Awards.  It is intended that this funding will increase opportunities for women to advance to senior positions in academic medicine.

How much is each award?
These are two year awards for $50,000 per year in direct costs, plus 15% for indirect costs.

When is the deadline?
Tuesday, November 9, 2021 - 5:00 PM

How do I learn more and apply?
Click here to read more and apply online. We encourage you to attend the Claflin Distinguished Scholar Awards Informational Panel Discussion on Wednesday, September 22 from 11:00am – 12:00pm. More information can be fund in the call for applications.

Please click here to enroll in the Claflin Consultation Initiative by Tuesday, September 28th.

 
4. NIMH Instrumentation Program

The NIMH Instrumentation Program (S10) encourages applications from NIH funded investigators that conduct mental health-related research to purchase or upgrade a single commercially available instrument or a group of components to create an instrument that is not commercially available. There is no maximum limit on the cost of the instrument, though the amount awarded by the NIH will be between $300,000 and $600,000.

The MGH Executive Committee on Research (ECOR) will commit funding to provide institutional support for NIMH S10 proposals. ECOR has made this commitment because it recognizes that institutional support greatly increases the likelihood that a S10 will be funded.

If you are interested in applying for this grant, please fill out this NIMH S10 application form and return it to ecor@mgh.harvard.edu by Tuesday, September 7, 2021We encourage applicants to continue working on their NIH application while ECOR reviews your internal LOI.  The LOI will be used to determine the level of institutional support to allocate to this funding opportunity, though we will reach out to you if there are any questions.  Applicants will receive a letter of institutional support required to submit the application to NIH.

The NIH deadline for applications is October 8, 2021, so we would greatly appreciate your notification of interest as soon as possible.

If you have questions, please contact MGH ECOR at ecor@mgh.harvard.edu or call 617-643-7420.

 
5. NIH Research Supplements to Promote Diversity in Health-Related Research

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

This administrative supplement is designed to provide support for research experiences for individuals from diverse backgrounds throughout the continuum from high school to the faculty level. Continuation of this program in the future will depend on the evaluation of the career outcomes of the supported individuals as well as continuing assessments of the diversity of the scientific workforce.

Please click here to learn more.

 
6. Job Research Foundation Announces 4th Round of Funding

$400,000 in Grants Available to Researchers Investigating Causes/Treatments of Rare Multisystem Immunodeficiency Disorder

The Job Research Foundation, which seeks to help find a cure for Job Syndrome by providing the global scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, has announced the fourth round of grant funding. The Foundation will award two two-year grants in the amount of $200,000 each to scientific researchers who are investigating the causes of, and treatments for, Job Syndrome. Grant applications can be found online at https://www.jobresearchfoundation.org/grant-proposal-application . Deadline to apply is October 15, 2021.

The long-term goal of the Foundation is to help advance research to find a cure for Job Syndrome. In the short term, the Foundation hopes the research will improve the treatments for patients suffering from the rare disorder.

To date the organization has funded a total of ten research projects across the world. In 2019, Job Research Foundation awarded four grants in the first round of funding to researchers from Australia, Spain, Germany, and the United States. In 2020, four grants were awarded to researchers in the United States and the United Kingdom in the second round of funding. This year’s recipients are based in the United States and in Germany.

Special consideration will be given to research focused on Job Syndrome and Pulmonary Function. Previous applicants can apply in subsequent years to extend their research. The application process is open to researchers world-wide and awardees will be announced between December 2021 and January 2022.

The Job Research Foundation seeks to not only help find a cure for Job Syndrome by providing the scientific community with additional opportunities to further research into the rare multisystem immunodeficiency disorder, but also hopes that investigators will research treatments to help those suffering with Job Syndrome. Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), was discovered in 1966 and is a multisystem immunodeficiency disorder found in males and females worldwide. Visit https://www.jobresearchfoundation.org/ for additional details.

 
7.  NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities

The National Institute of Neurological Disorders and Stroke seeks to promote diversity in all of its research programs and to increase the participation of underrepresented groups. As the US population becomes increasingly diverse, reflection of that diversity among the biomedical research workforce is vital to our science enterprise and the NIH research mission (See NOT-OD-20-031). NIH is committed to implementing approaches to address the funding gap for researchers from diverse backgrounds and “committed to instituting new ways to support diversity, equity, and inclusion, and identifying and dismantling any policies and practices that may harm our workforce and our science”.

This NOSI utilizes the NIH parent R01 announcement to encourage Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) from diverse backgrounds to conduct and contribute to the research areas of the NINDS.

This notice applies to due dates on or after June 5, 2021 and subsequent receipt dates through May 8, 2023. 

Click here to learn more.

 
8. T32 Postdoctoral Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease and Related Dementia (PET/MR in ADRD) - T32 AG066592

The primary mission of this program is to promote the development of a diverse, translational research workforce that is capable of participating and/or leading cross-disciplinary team science relevant for the treatment and prevention of Alzheimer’s disease and AD-related dementias.  The trainee will pursue a targeted research project under the mentorship of world-class researchers in the Harvard research community in three key areas:
[1] biology of aging and neurodegeneration;
[2] data sciences, computational biology, statistics, math/engineering/physics;
[3] drug discovery and development
Most T32 faculty are within the MGH Martinos Center for Biomedical Imaging and/or Massachusetts Alzheimer’s Disease Research Center.  Training includes targeted coursework, didactic lectures, and a dedicated T32 lecture series. General training includes research conduct, diversity and inclusion, mentoring, career development, and grant development activities.

Eligibility: PhD, MD, MD/PhD and U.S. citizen or permanent resident (see NIH PAR-18-524), with rolling admission for 4 training slots.  Our goal is to recruit a truly diverse T32 trainee pool that is highly representative of URM and women trainees.

Additional information: Please see  https://pricelab.martinos.org/t32-adrd/ for further information including application instructionsPlease submit questions to:  Krystal Whitfield (T32 Administrative Contact) at T32ADRD@mgh.harvard.edu

 
9. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process            
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award

If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities                                                                                                                                        
Please click here for more information and for our internal deadlines.

  • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 – Clinical Trial Not Allowed)
  • Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (R25 Clinical Trial Not Allowed)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
10. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 09/03/21

  • AGA-Takeda Pharmaceuticals Research Scholar Award in Celiac Disease, AGA Research Foundation/American Gastroenterological Association (AGA). $300,000. Application Deadline: November 10
  • Research Scholar Award (RSA), AGA Research Foundation/American Gastroenterological Association (AGA). $300,000. Application Deadline: November 10
  • Research Grant Program, Barth Syndrome Foundation, Inc. (BSF). $100,000. LOI Deadline: September 15
  • Career Development Award, Foundation Fighting Blindness (FFB). $375,000. February 1
  • Diana Davis Spencer Clinical Research Fellowship Award Program in Inherited Orphan Retinal Degenerations, Foundation Fighting Blindness (FFB). $65,000. Application Deadline: October 21
  • Individual Investigator Research Grant, Foundation Fighting Blindness (FFB). $300,000. LOI Deadline: November 5
  • Research Grants, International Foundation for Research in Paraplegia (IRP). ≈ $163,000. Application Deadline: October 31
  • RETpositive/LUNGevity Award for RET-positive Lung Cancer Research, LUNGevity Foundation NEW! $200,000. LOI Deadline: September 17
  • Biomedical Research Project Grants, Motor Neurone Disease Association (MNDA) (MND Association). ≈ $352,000. Stage 1 Application Deadline: October 29
  • Early Career Research Grants, Terri Brodeur Breast Cancer Foundation (TBBCF). $100,000. Application Deadline: November 21
 
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

MGH Town Hall Meeting Recordings

MGB Community Connects

Mentor MGB

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending September 3, 2021

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

Your email address is currently listed as:%%emailaddr%%.

Click here to edit your profile or to change your email address for receipt of information about MGH Research.

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu